Patients with lupus nephritis who received hydroxychloroquine demonstrated a significantly lower risk for glomerular ...
Novartis' Fabhalta showed significant efficacy and safety in a Phase 3 IgA nephropathy study, supporting regulatory filings ...
Novartis has spent considerable time and energy building its presence in the IgA nephropathy (IgAN) disease area, and now | ...
Please provide your email address to receive an email when new articles are posted on . Older adults may have hyperfiltration with normal glomerular filtration rate calculation. GFR calculation may be ...
Zacks Investment Research on MSN
NVS Reports Positive Late-Stage Data on Kidney Disease Drug
Novartis NVS recently announced positive final results from the late-stage, APPLAUSE-IgAN, study on Fabhalta (iptacopan) in ...
A new study published in the journal of Pediatric Nephrology revealed an U-shaped relationship between serum uric acid levels and cardiovascular risk in children with chronic kidney disease ...
Opinion
MedPage Today on MSNSpotting Trends in Patients' Tests
Statistics, and the standard deviation of our tests, mean that if you order a complete metabolic profile, a lipid panel, a ...
A prospective population-based cohort study found that glomerular filtration rate based on cystatin C was more sensitive and specific for cardiovascular disease (CVD) and mortality risks compared with ...
Patients with chronic hepatitis B (CHB) have an increased prevalence of chronic kidney disease (CKD), according to a study ...
I recently took a call from a new practitioner. She had an 85-year-old diabetic, non-insulin-dependent female with a glomerular filtration rate (GFR) of 45 mL/min/1.73 m 2. The practitioner asked if ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results